Articles with public access mandates - Michael GlantzLearn more
Not available anywhere: 3
External ventricular drain practice variations: results from a nationwide survey
GR Baum, KG Hooten, DT Lockney, KM Fargen, N Turan, G Pradilla, ...
Journal of neurosurgery 127 (5), 1190-1197, 2017
Mandates: US National Institutes of Health
PHASE 2 STUDY OF IBRUTINIB WITH TEMOZOLOMIDE, ETOPOSIDE, LIPOSOMAL DOXORUBICIN, DEXAMETHASONE, RITUXIMAB (TEDDI‐R) FOR SECONDARY CNS LYMPHOMA.
M Roschewski, J Simard, C Melani, R Lakhotia, JD Phelan, S Pittaluga, ...
Hematological Oncology 41, 2023
Mandates: US National Institutes of Health
Extent of Resection and Survival in Glioblastoma Multiforme—Reply
TJ Brown, M Glantz
JAMA oncology 2 (11), 1509-1510, 2016
Mandates: US National Institutes of Health
Available somewhere: 23
Association of the extent of resection with survival in glioblastoma: a systematic review and meta-analysis
TJ Brown, MC Brennan, M Li, EW Church, NJ Brandmeir, KL Rakszawski, ...
JAMA oncology 2 (11), 1460-1469, 2016
Mandates: US National Institutes of Health
Neutrophil-induced ferroptosis promotes tumor necrosis in glioblastoma progression
PP Yee, Y Wei, SY Kim, T Lu, SY Chih, C Lawson, M Tang, Z Liu, ...
Nature communications 11 (1), 5424, 2020
Mandates: US National Institutes of Health
A randomized double-blind placebo-controlled phase II trial of dendritic cell vaccine ICT-107 in newly diagnosed patients with glioblastoma
PY Wen, DA Reardon, TS Armstrong, S Phuphanich, RD Aiken, ...
Clinical Cancer Research 25 (19), 5799-5807, 2019
Mandates: US National Institutes of Health
Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications
A Boire, D Brandsma, PK Brastianos, E Le Rhun, M Ahluwalia, L Junck, ...
Neuro-oncology 21 (5), 571-584, 2019
Mandates: US National Institutes of Health
Management of low-grade glioma: a systematic review and meta-analysis
TJ Brown, DA Bota, MJ van Den Bent, PD Brown, E Maher, D Aregawi, ...
Neuro-oncology practice 6 (4), 249-258, 2019
Mandates: US National Institutes of Health, Government of Spain
Thrombin-cleaved fragments of osteopontin are overexpressed in malignant glial tumors and provide a molecular niche with survival advantage
Y Yamaguchi, Z Shao, S Sharif, XY Du, T Myles, M Merchant, G Harsh, ...
Journal of Biological Chemistry 288 (5), 3097-3111, 2013
Mandates: US National Institutes of Health
Selective detection of the D-enantiomer of 2-hydroxyglutarate in the CSF of glioma patients with mutated isocitrate dehydrogenase
J Kalinina, J Ahn, NS Devi, L Wang, Y Li, JJ Olson, M Glantz, T Smith, ...
Clinical Cancer Research 22 (24), 6256-6265, 2016
Mandates: US National Institutes of Health
Preliminary use of differential scanning calorimetry of cerebrospinal fluid for the diagnosis of glioblastoma multiforme
AA Chagovetz, RL Jensen, L Recht, M Glantz, AM Chagovetz
Journal of neuro-oncology 105, 499-506, 2011
Mandates: US National Institutes of Health
Impact of provider level, training and gender on the utilization of palliative care and hospice in neuro-oncology: a North-American survey
T Walbert, M Glantz, L Schultz, VK Puduvalli
Journal of neuro-oncology 126, 337-345, 2016
Mandates: US National Institutes of Health
Deconvoluting Mechanisms of Acquired Resistance to RAF Inhibitors in BRAFV600E-Mutant Human Glioma
KC Schreck, A Morin, G Zhao, AN Allen, P Flannery, M Glantz, AL Green, ...
Clinical Cancer Research 27 (22), 6197-6208, 2021
Mandates: US National Institutes of Health
An interstitial deletion within 9p21. 3 and extending beyond CDKN2A predisposes to melanoma, neural system tumours and possible haematological malignancies
MJ Baker, AM Goldstein, PL Gordon, KS Harbaugh, HB Mackley, ...
Journal of medical genetics 53 (11), 721-727, 2016
Mandates: US National Institutes of Health
Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419)
C Hertler, J Felsberg, D Gramatzki, E Le Rhun, J Clarke, R Soffietti, ...
European Journal of Cancer 189, 112913, 2023
Mandates: American Brain Tumor Association
COX-2 drives metastatic breast cells from brain lesions into the cerebrospinal fluid and systemic circulation
JE Allen, AS Patel, VV Prabhu, DT Dicker, JM Sheehan, MJ Glantz, ...
Cancer research 74 (9), 2385-2390, 2014
Mandates: US National Institutes of Health
Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trial
T Ranjan, S Sengupta, MJ Glantz, RM Green, A Yu, D Aregawi, ...
Cell Reports Medicine 4 (5), 2023
Mandates: US National Institutes of Health
Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 US cancer centers
KA David, S Sundaram, SH Kim, R Vaca, Y Lin, S Singer, MK Malecek, ...
American journal of hematology 98 (6), 900-912, 2023
Mandates: US National Institutes of Health
Temporal radiographic and histological study of necrosis development in a mouse glioblastoma model
PP Yee, J Wang, SY Chih, DG Aregawi, MJ Glantz, BE Zacharia, ...
Frontiers in Oncology 12, 993649, 2022
Mandates: US National Institutes of Health
Leveraging the CSF proteome toward minimally-invasive diagnostics surveillance of brain malignancies
N Mikolajewicz, S Khan, M Trifoi, A Skakdoub, V Ignatchenko, S Mansouri, ...
Neuro-Oncology Advances 4 (1), vdac161, 2022
Mandates: Canadian Institutes of Health Research
Publication and funding information is determined automatically by a computer program